SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001976408-23-000005
Filing Date
2023-05-16
Accepted
2023-05-16 17:36:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2792
  Complete submission text file 0001976408-23-000005.txt   4123
Mailing Address 3338 LANCASHIRE RD FURLONG PA 18925
Business Address
Rowland Charles A Jr (Reporting) CIK: 0001383292 (see all company filings)

Type: 144

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Subject) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37355 | Film No.: 23928888
SIC: 2834 Pharmaceutical Preparations